Close Menu

Haemonetics Corporation announced Thursday it has acquired the outstanding share capital of German blood coagulation test system developer Enicor.

Financial and other terms of the deal were not disclosed.

Enicor's ClotPro system is a viscoelastic device with an active tip that reduces manual pipetting, mitigating potential errors and eliminating reagent handling, the company said. The ClotPro system received a CE mark last year and is available in certain European and Asian Pacific markets.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.